{"mainPropery":{"diseaseId":10739,"diseaseName":"Neuronal ceroid lipofuscinosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10739/neuronal-ceroid-lipofuscinosis","synonyms":["Batten disease","NCL"],"synonyms-with-source":[{"name":"Batten disease","source":"GeneReview"},{"name":"NCL","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"216"},{"identifierType":"UMLS","identifierId":"C0027877"}]},"diseaseCategories":[{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases"}],"organizations":[{"resourceID":315,"resourceName":"Batten Disease Support and Research Association","abbreviation":"BDSRA","address1":"2780 Airport Drive, Suite 342","address2":"","address3":"","address4":"","address5":"","city":"Columbus","state":"OH","zip":"43219","country":"United States","phone":"","tty":"","tollFree":"1-800-448-4570","fax":"1-866-648-8718","email":"https://bdsra.org/contact-us/","url":"https://bdsra.org/","freeText":""},{"resourceID":2239,"resourceName":"Beyond Batten Disease Foundation","abbreviation":"","address1":"PO Box 50221","address2":"","address3":"","address4":"","address5":"","city":"Austin","state":"TX","zip":"78763","country":"","phone":"+1-512-275-2600","tty":"","tollFree":"1-877-6BATTEN","fax":"512-637-6333","email":"info@beyondbatten.org","url":"https://beyondbatten.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed?term=%22Neuronal%20ceroid%20lipofuscinosis%22%5Btitle%5D%20AND%20hasabstract%5Btext%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neuronal ceroid lipofuscinosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://www.clinicaltrials.gov/ct2/results?cond=%22Neuronal+ceroid+lipofuscinoses%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Neuronal ceroid lipofuscinosis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='https://www.ncbi.nlm.nih.gov/gtr/conditions/C0027877/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='https://medlineplus.gov/ency/article/001613.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Batten-Disease-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke (NINDS)</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='https://emedicine.medscape.com/article/1178391-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=216' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/books/NBK1428/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:14503' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Neuronal ceroid lipofuscinosis. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Neuronal ceroid lipofuscinosis:<br />\r\n<a href='https://www.urmc.rochester.edu/neurology/batten-disease-center/research/research-clinical-trials.aspx' target='_blank'>Batten Disease Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":9368,"questionText":"What is neuronal ceroid lipofuscinosis?","answerText":"<strong>Neuronal ceroid lipofuscinosis (NCL)</strong> refers to a group of conditions that affect the nervous system. Signs and symptoms vary widely between the forms but generally include a combination of <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000739.htm\" target=\"_blank\">dementia</a>, vision loss, and epilepsy. Although the NCLs were historically classified according to their age of onset and clinical symptoms, the most recent classification system is primarily based on their underlying <a href=\"http://omim.org/phenotypicSeries/PS256730\" target=\"_blank\">genetic cause</a>. Most forms are inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> manner; however,&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> inheritance has been reported in one adult-onset form (<a href=\"https://rarediseases.info.nih.gov/gard/1222/autosomal-dominant-neuronal-ceroid-lipofuscinosis-4b/resources/1\" target=\"_blank\">neuronal ceroid lipofuscinosis 4B</a>). Treatment options are limited to therapies that can help relieve some of the symptoms.[9561][9562]<br />\r\n<br />\r\nThe Batten Disease Support and Research Association (BDSRA) has more information about the different types of NCL.<br />\r\n<ul>\r\n    <li>BDSRA: <a href=\"https://bdsra.org/types-of-batten-disease/\" target=\"_blank\">Summary of new classification nomenclature of the NCLs</a></li>\r\n</ul>\r\n<em>Please note</em>: Batten disease originally referred specifically to the juvenile and most common form of NCL, now known as&nbsp;<a href=\"https://rarediseases.info.nih.gov/diseases/5897/neuronal-ceroid-lipofuscinosis-3\" target=\"_blank\">CLN3</a>. However, the term Batten disease is increasingly used to describe all forms of NCL. All types of NCL also belong to a larger group of diseases known as&nbsp;<a href=\"https://rarediseases.org/rare-diseases/lysosomal-storage-disorders/\" target=\"_blank\">lysosomal storage disorders</a>.[9561]","dateModified":"2015-09-07T19:54:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":10973,"relatedDiseaseName":"Adult neuronal ceroid lipofuscinosis","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":1222,"relatedDiseaseName":"Autosomal dominant neuronal ceroid lipofuscinosis 4B","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":1219,"relatedDiseaseName":"Ceroid lipofuscinosis neuronal 1","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":1218,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis 10 ","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":3045,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis 2","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":5897,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis 3","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":1223,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis 5","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":1224,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis 6","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":1220,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis 7","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":6618,"relatedDiseaseName":"Neuronal ceroid lipofuscinosis 9","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":4010,"relatedDiseaseName":"Northern epilepsy","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5621,"phenoTypeName":"Abnormal electroretinogram","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14446,"phenoTypeName":"Abnormal retinal vascular morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8727,"phenoTypeName":"Mental deterioration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3022,"phenoTypeName":"Ocular albinism","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9162,"phenoTypeName":"Visual loss","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13037,"phenoTypeName":"Abnormality of metabolism/homeostasis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11464,"phenoTypeName":"Abnormality of movement","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13842,"phenoTypeName":"Neurological speech impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6005,"phenoTypeName":"Behavioral abnormality","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Neuronal_ceroid_lipofuscinosis"}